Treatment-free Remission Accomplished With Dasatinib in Patients With CML

PHASE2UnknownINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2021

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Dasatinib

Trial Locations (12)

Unknown

Tom Baker Cancer Center, Calgary

University of Alberta Hospital, Edmonton

Cancer Care Manitoba, Winnipeg

Queen Elizabeth II Health Sciences Centre, Halifax

Juravinski Cancer Centre, Hamilton

London Health Sciences Centre, London

Ottawa General Hospital, Ottawa

Centre Hôpitallier Universitaire de Quebec - Hôpital de l'Enfant-Jésus, Charlesbourg

Hopital Maisonneuve-Rosemont, Montreal

McGill University Health Centre, Montreal

V5Z1M9

Vancouver General Hospital, Vancouver

M5G 2M9

Princess Margaret Cancer Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ozmosis Research Inc.

INDUSTRY

lead

University Health Network, Toronto

OTHER